121 related articles for article (PubMed ID: 34328715)
1. Surface Decoration via Physical Interaction of Cupric Diethyldithiocarbamate Nanocrystals and Its Impact on Biodistribution and Tumor Targeting.
Meng Z; Wang H; Fang X; Liu Z; Yang Z; Yong J; Yang Q; Bai Y; Ren H; Xu H; Li X
ACS Appl Mater Interfaces; 2021 Aug; 13(31):36894-36908. PubMed ID: 34328715
[TBL] [Abstract][Full Text] [Related]
2. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale Copper(II)-Diethyldithiocarbamate Coordination Polymer as a Drug Self-Delivery System for Highly Robust and Specific Cancer Therapy.
Peng Y; Liu P; Meng Y; Hu S; Ding J; Zhou W
Mol Pharm; 2020 Aug; 17(8):2864-2873. PubMed ID: 32551674
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy.
Xiao C; Li J; Wang X; Li S; Xu C; Zhang Z; Hua A; Ding ZY; Zhang BX; Yang X; Li Z
J Control Release; 2023 Apr; 356():288-305. PubMed ID: 36870542
[TBL] [Abstract][Full Text] [Related]
5. Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins.
Xu J; Lee SS; Seo H; Pang L; Jun Y; Zhang RY; Zhang ZY; Kim P; Lee W; Kron SJ; Yeo Y
Small; 2018 Dec; 14(50):e1803601. PubMed ID: 30411856
[TBL] [Abstract][Full Text] [Related]
6. Dual Action of Acidic Microenvironment on the Enrichment of the Active Metabolite of Disulfiram in Tumor Tissues.
Tang C; Pang X; Guo Z; Guo R; Liu L; Chen X
Drug Metab Dispos; 2021 Jun; 49(6):434-441. PubMed ID: 33762296
[TBL] [Abstract][Full Text] [Related]
7. Preparation and anticancer actions of CuET-nanoparticles dispersed by bovine serum albumin.
He Y; Yang M; Yang L; Hao M; Wang F; Li X; Taylor EW; Zhang X; Zhang J
Colloids Surf B Biointerfaces; 2023 Jun; 226():113329. PubMed ID: 37156027
[TBL] [Abstract][Full Text] [Related]
8. Copper(II)-disulfiram loaded melanin-dots for cancer theranostics.
Shi H; Suo Y; Zhang Z; Liu R; Liu H; Cheng Z
Nanomedicine; 2021 Feb; 32():102340. PubMed ID: 33227540
[TBL] [Abstract][Full Text] [Related]
9. P-selectin is a nanotherapeutic delivery target in the tumor microenvironment.
Shamay Y; Elkabets M; Li H; Shah J; Brook S; Wang F; Adler K; Baut E; Scaltriti M; Jena PV; Gardner EE; Poirier JT; Rudin CM; Baselga J; Haimovitz-Friedman A; Heller DA
Sci Transl Med; 2016 Jun; 8(345):345ra87. PubMed ID: 27358497
[TBL] [Abstract][Full Text] [Related]
10. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
[TBL] [Abstract][Full Text] [Related]
11. Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer.
Saren BN; Mahajan S; Aalhate M; Kumar R; Chatterjee E; Maji I; Gupta U; Guru SK; Singh PK
Colloids Surf B Biointerfaces; 2024 Jan; 233():113631. PubMed ID: 37979483
[TBL] [Abstract][Full Text] [Related]
12. One-Step Synthesis of Nanoliposomal Copper Diethyldithiocarbamate and Its Assessment for Cancer Therapy.
Paun RA; Dumut DC; Centorame A; Thuraisingam T; Hajduch M; Mistrik M; Dzubak P; De Sanctis JB; Radzioch D; Tabrizian M
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336014
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles assembled from fucoidan and trimethylchitosan as anthrax vaccine adjuvant: In vitro and in vivo efficacy in comparison to CpG.
Tsai MH; Chuang CC; Chen CC; Yen HJ; Cheng KM; Chen XA; Shyu HF; Lee CY; Young JJ; Kau JH
Carbohydr Polym; 2020 May; 236():116041. PubMed ID: 32172855
[TBL] [Abstract][Full Text] [Related]
14. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
Chen W; Yang W; Chen P; Huang Y; Li F
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
[TBL] [Abstract][Full Text] [Related]
15. Enhanced anticancer effect of ROS-boosted photothermal therapy by using fucoidan-coated polypyrrole nanoparticles.
Lu KY; Jheng PR; Lu LS; Rethi L; Mi FL; Chuang EY
Int J Biol Macromol; 2021 Jan; 166():98-107. PubMed ID: 33091478
[TBL] [Abstract][Full Text] [Related]
16. Repurposing disulfiram with CuET nanocrystals: Enhancing anti-pyroptotic effect through NLRP3 inflammasome inhibition for treating inflammatory bowel diseases.
Xu X; Han Y; Deng J; Wang S; Zhuo S; Zhao K; Zhou W
Acta Pharm Sin B; 2024 Jun; 14(6):2698-2715. PubMed ID: 38828135
[TBL] [Abstract][Full Text] [Related]
17. Development of quinic acid-conjugated nanoparticles as a drug carrier to solid tumors.
Amoozgar Z; Park J; Lin Q; Weidle JH; Yeo Y
Biomacromolecules; 2013 Jul; 14(7):2389-95. PubMed ID: 23738975
[TBL] [Abstract][Full Text] [Related]
18. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
19. Orchestrating Precision within the Tumor Microenvironment by Biomimetic Nanoprodrugs for Effective Tumor Therapy.
Wang Y; Xu H; Huang X; Zhang Y; Lu Y; Cheng J; Xu X; Li J; Yao H; Chen X
ACS Appl Mater Interfaces; 2024 Feb; 16(7):8484-8498. PubMed ID: 38334265
[TBL] [Abstract][Full Text] [Related]
20. Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine
Lu Y; Pan Q; Gao W; Pu Y; He B
J Mater Chem B; 2022 Aug; 10(33):6296-6306. PubMed ID: 35904024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
